Use of Trimetazidine in the Combined Therapy of Myocardial Infarction with Left Ventricular Disfunction

[No abstract available]

Авторы
Terestchenko S.N.1 , Alexandria L.G.1 , Moiseev V.S.1
Редакторы
-
Журнал
Издательство
KlinMed Consulting
Номер выпуска
10
Язык
Русский
Страницы
19-21
Статус
Опубликовано
Подразделение
-
DOI
-
Номер
-
Том
42
Год
2002
Организации
  • 1 Russia Univ. of Friendship People, Vavilova, 61, 117292 Moscow, Russian Federation
Ключевые слова
acetylsalicylic acid; anticoagulant agent; antithrombocytic agent; beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; fibrinolytic agent; glyceryl trinitrate; heparin; trimetazidine; vasodilator agent; article; clinical trial; comparative study; controlled clinical trial; controlled study; Doppler echocardiography; drug combination; echocardiography; female; fibrinolytic therapy; follow up; heart infarction; heart left ventricle function; heart ventricle remodeling; hemodynamics; human; intravenous drug administration; male; middle aged; pathophysiology; randomized controlled trial; time; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Diuretics; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Fibrinolytic Agents; Follow-Up Studies; Hemodynamic Processes; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling
Дата создания
19.10.2018
Дата изменения
19.10.2018
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/135/